HBV capsid inhibitors (Arbutus Biopharma)

N/A

Report date: 2025/03/20 15:46:30
NME

Base Information

Drug NameHBV capsid inhibitors (Arbutus Biopharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArbutus Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesArbutus Biopharma Corp
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A